Rheumatoid arthritis and cardiovascular disease

被引:251
作者
Crowson, Cynthia S. [1 ]
Liao, Katherine P. [2 ,3 ]
Davis, John M., III [1 ]
Solomon, Daniel H. [2 ,3 ]
Matteson, Eric L. [1 ]
Knutson, Keith L. [1 ]
Hlatky, Mark A. [4 ]
Gabriel, Sherine E. [1 ]
机构
[1] Mayo Clin, Rochester, MN USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Stanford Univ, Sch Med, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
IMPROVES ENDOTHELIAL FUNCTION; NONCARDIAC VASCULAR-DISEASE; T-CELLS; GASTROINTESTINAL TOXICITY; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; ARTERIAL STIFFNESS; TELOMERIC LOSS; HEART-FAILURE; LIPID PROFILE;
D O I
10.1016/j.ahj.2013.07.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Rheumatic disease and heart disease share common underpinnings involving inflammation. The high levels of inflammation that characterize rheumatic diseases provide a "natural experiment" to help elucidate the mechanisms by which inflammation accelerates heart disease. Rheumatoid arthritis (RA) is the most common of the rheumatic diseases and has the best studied relationships with heart disease. Methods A review of current literature on heart disease and RA was conducted. Results Patients with RA have an increased risk of developing heart disease that is not fully explained by traditional cardiovascular risk factors. Therapies used to treat RA may also affect the development of heart disease; by suppressing inflammation, they may also reduce the risk of heart disease. However, their other effects, as in the case of steroids, may increase heart disease risk. Conclusions Investigations of the innate and adaptive immune responses occurring in RA may delineate novel mechanisms in the pathogenesis of heart disease and help identify novel therapeutic targets for the prevention and treatment of heart disease.
引用
收藏
页码:622 / +
页数:8
相关论文
共 79 条
  • [1] Rheumatoid arthritis and macrovascular disease
    Alkaabi, JK
    Ho, M
    Levison, R
    Pullar, T
    Belch, JJF
    [J]. RHEUMATOLOGY, 2003, 42 (02) : 292 - 297
  • [2] Tumor Necrosis Factor-α Antagonists Improve Aortic Stiffness in Patients With Inflammatory Arthropathies A Controlled Study
    Angel, Kristin
    Provan, Sella Aarrestad
    Gulseth, Hanne Lovdahl
    Mowinckel, Petter
    Kvien, Tore Kristian
    Atar, Dan
    [J]. HYPERTENSION, 2010, 55 (02) : 333 - 338
  • [3] Statins inhibit the antirheumatic effects of rituximab in rheumatoid arthritis: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry
    Arts, E. E. A.
    Jansen, T. L.
    Den Broeder, A.
    Vonkeman, H. E.
    Dutmer, E.
    Van de Laar, M. A. F. J.
    Van Riel, P. L. C. M.
    Fransen, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (05) : 877 - 878
  • [4] Noncardiac vascular disease in rheumatoid arthritis: Increase in venous thromboembolic events?
    Bacani, A. Kirstin
    Gabriel, Sherine E.
    Crowson, Cynthia S.
    Heit, John A.
    Matteson, Eric L.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (01): : 53 - 61
  • [5] Systematic Review and Meta-Analysis: Anti-Tumor Necrosis Factor α Therapy and Cardiovascular Events in Rheumatoid Arthritis
    Barnabe, Cheryl
    Martin, Billie-Jean
    Ghali, William A.
    [J]. ARTHRITIS CARE & RESEARCH, 2011, 63 (04) : 522 - 529
  • [6] Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis
    Becker, Matthew C.
    Wang, Thomas H.
    Wisniewski, Lisa
    Wolski, Kathy
    Libby, Peter
    Luescher, Thomas F.
    Borer, Jeffrey S.
    Mascette, Alice M.
    Husni, M. Elaine
    Solomon, Daniel H.
    Graham, David Y.
    Yeomans, Neville D.
    Krum, Henry
    Ruschitzka, Frank
    Lincoff, A. Michael
    Nissen, Steven E.
    [J]. AMERICAN HEART JOURNAL, 2009, 157 (04) : 606 - 612
  • [7] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
    Bombardier, C
    Laine, L
    Reicin, A
    Shapiro, D
    Burgos-Vargas, R
    Davis, B
    Day, R
    Ferraz, MB
    Hawkey, CJ
    Hochberg, MC
    Kvien, TK
    Schnitzer, TJ
    Weaver, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) : 1520 - 1528
  • [8] Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis
    Colmegna, Ins
    Diaz-Borjon, Alejandro
    Fujii, Hiroshi
    Schaefer, Linda
    Goronzy, Joerg J.
    Weyand, Cornelia M.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (04): : 990 - 1000
  • [9] Cooney Jennifer K, 2011, J Aging Res, V2011, P681640, DOI 10.4061/2011/681640
  • [10] The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population
    Davis, John M., III
    Roger, Veronique L.
    Crowson, Cynthia S.
    Kremers, Hilal Maradit
    Therneau, Terry M.
    Gabriel, Sherine E.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : 2603 - 2611